The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer.
Benedikt Engels
No relevant relationships to disclose
Thierry Gevaert
No relevant relationships to disclose
Hendrik Everaert
No relevant relationships to disclose
Alexandra Sermeus
No relevant relationships to disclose
Guy Storme
No relevant relationships to disclose
Dirk Verellen
No relevant relationships to disclose
Mark De Ridder
No relevant relationships to disclose